Terri B. Sebree
2022
In 2022, Terri B. Sebree earned a total compensation of $1.4M as President at Zynerba Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,710 |
|---|---|
| Option Awards | $242,413 |
| Salary | $486,236 |
| Stock Awards | $409,700 |
| Other | $17,204 |
| Total | $1,381,263 |
Sebree received $486.2K in salary, accounting for 35% of the total pay in 2022.
Sebree also received $225.7K in non-equity incentive plan, $242.4K in option awards, $409.7K in stock awards and $17.2K in other compensation.
Rankings
In 2022, Terri B. Sebree's compensation ranked 2,397th out of 5,672 executives tracked by ExecPay. In other words, Sebree earned more than 57.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,397 out of 5,672 | 58th |
Division Manufacturing | 1,315 out of 3,081 | 57th |
Major group Chemicals And Allied Products | 587 out of 1,396 | 58th |
Industry group Drugs | 542 out of 1,297 | 58th |
Industry Pharmaceutical Preparations | 390 out of 940 | 59th |
Source: SEC filing on April 21, 2023.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2022.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019